Recomendaciones sobre el uso e indicaciones del tratamiento tópico en pacientes con colitis ulcerosa

D. Ginard , I. Marín-Jiménez , M. Barreiro de Acosta , E. Ricart , E. Domènech , J.P. Gisbert , M. Esteve , M. Mínguez , en representación de GETECCU
{"title":"Recomendaciones sobre el uso e indicaciones del tratamiento tópico en pacientes con colitis ulcerosa","authors":"D. Ginard ,&nbsp;I. Marín-Jiménez ,&nbsp;M. Barreiro de Acosta ,&nbsp;E. Ricart ,&nbsp;E. Domènech ,&nbsp;J.P. Gisbert ,&nbsp;M. Esteve ,&nbsp;M. Mínguez ,&nbsp;en representación de GETECCU","doi":"10.1016/j.eii.2015.06.002","DOIUrl":null,"url":null,"abstract":"<div><p>Although most patients with ulcerative colitis should be treated with topical treatment, different studies have shown that they are underused. The purpose of this article is to answer 10 specific questions about which drugs are available for topical use in the treatment of ulcerative colitis, and their characteristics in terms of formulation, dosage, presentation, application and proximal distribution of rectal-administered drugs. The efficacy of the available topical drugs and the benefits of combining different formulations and routes of administration, and their usefulness during disease remission is evaluated. Finally, some recommendations are given to better inform patients about the proper implementation and administration of topical treatment.</p></div>","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.06.002","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedad Inflamatoria Intestinal al Día","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S169678011500041X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Although most patients with ulcerative colitis should be treated with topical treatment, different studies have shown that they are underused. The purpose of this article is to answer 10 specific questions about which drugs are available for topical use in the treatment of ulcerative colitis, and their characteristics in terms of formulation, dosage, presentation, application and proximal distribution of rectal-administered drugs. The efficacy of the available topical drugs and the benefits of combining different formulations and routes of administration, and their usefulness during disease remission is evaluated. Finally, some recommendations are given to better inform patients about the proper implementation and administration of topical treatment.

溃疡性结肠炎患者局部治疗的使用建议和适应症
虽然大多数溃疡性结肠炎患者应该接受局部治疗,但不同的研究表明,它们没有得到充分利用。本文的目的是回答关于哪些药物可用于治疗溃疡性结肠炎的10个具体问题,以及它们在直肠给药的配方、剂量、表现、应用和近端分布方面的特点。评估现有外用药物的疗效和结合不同配方和给药途径的益处,以及它们在疾病缓解期间的有用性。最后,提出了一些建议,以便更好地告知患者局部治疗的正确实施和管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信